NCT07204756NARecruiting

HOPE-BP 2.0: Evaluating the Optimal Duration of Postpartum Remote Blood Pressure Monitoring

University of Minnesota

Start Date

1/7/2026

Completion Date

1/31/2028

Summary

Postpartum remote blood pressure monitoring programs for patients with hypertensive disorders of pregnancy (HDP) are becoming part of standard postpartum management. Existing programs range in duration from 2 to 6 weeks but there has not been any evaluation as to what program duration is optimal. The primary objective of this study is to evaluate the impact of program duration on clinical outcomes for patients participating in a single institution's postpartum remote blood pressure monitoring program for patients with HDP.

Eligibility Criteria

Age Range: 18 years to No maximum

Inclusion Criteria: * 18 years or older * Discharged after delivery at University of Minnesota Medical Center * Enrolled into the HOPE-BP Program Exclusion Criteria: * Ongoing antihypertensive medication use at 2 weeks (time of randomization) * Have a medical comorbidity that would not be clinically appropriate to randomize * Patients opted out of clinical research

Interventions

DIAGNOSTIC_TEST

2-Week Home Monitoring

DIAGNOSTIC_TEST

6-Week Home Monitoring

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

PostpartumHypertensionHypertensive Disorder of Pregnancy

Locations

University of Minnesota

Minneapolis, Minnesota 55455

United States